MicroGenSys drops out of NIH trial for AIDS vaccine
Article Abstract:
MicroGenSys Inc withdrew its gp160 vaccine from trials planned bythe AIDS Clinical Trials Group of the US National Institutes of Health (NIH). MicroGenSys cited the proposed dosing schedule, the duration of the study and the criteria used to evaluate the vaccine as the primary reasons for its withdrawal. The same vaccine drew similar controversy in the autumn of 1992 when MicroGenSys successfully persuaded Congress to give the US Army $20 million for large-scale clinical trials for the vaccine. The NIH criticized this move, and as a result, will probably proceed with the evaluation of gp120 vaccines produced by Genentech and Chiron.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Researchers recommend US AIDS vaccine trials
Article Abstract:
A panel of researchers and AIDS activists agree that unproven drugs for fighting the AIDS virus should be tested on a large scale. The Army may spend $20 million appropriated by Congress for AIDS research on a trial of MicroGeneSys Inc.'s GP-160 AIDS vaccine. The Director of the National Institutes of Health objected to the decision to test the drug without adequate scientific testimony of the drug's efficacy.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Changing the face of training for science at the interface. Researchers urge boycott of supply company in labour dispute with warehouse employees
- Abstracts: Renewable energy may fall off Britain's research agenda. UK agricultural funding leans towards policy. UK panels need more clout
- Abstracts: Pictures of MHC restriction. The duck's dilemma. Flying the first class flag
- Abstracts: Functional diversity of helper T lymphocytes. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection
- Abstracts: Effects of lamb age, muscle type, and 24-hour activity of endogenous proteinases on postmortem proteolysis. The effect of postmortem time of injection and freezing on the effectiveness of calcium chloride for improving beef tenderness